1. Ohguro N, Sonoda KH, Takeuchi M, Matsumura M, Mochizuki M. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432–5.
2. Nakae K, Masaki F, Hashimoto F, Inaba G, Mochizuki M, Sakane T. Recent epidemiological features of Behçet’s disease in Japan. In: Godeau P, Wechsler B, editors. Behçet’s disease. Amsterdam: Excerpta Medica; 1993. p. 145–51.
3. Mochizuki M, Akduman L, Nussenblatt RB. Behçet disease. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. St. Louis: Mosby; 1996. p. 663–75.
4. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50:297–350.
5. Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet’s disease with refractory uveoretinitis. J Rheumatol. 2004;31:1362–8.